id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-E-0627-0007,FDA,FDA-2016-E-0627,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2018-01-29T05:00:00Z,2018,1,2018-01-29T05:00:00Z,,2018-01-29T20:39:18Z,,0,0,0900006482e79f71
FDA-2016-E-0627-0006,FDA,FDA-2016-E-0627,"Determination of Regulatory Review Period for Purposes of Patent
Extension; Intercept Blood System for Platelets",Notice,Determinations,2017-07-11T04:00:00Z,2017,7,2017-07-11T04:00:00Z,2017-09-12T03:59:59Z,2017-07-11T14:07:02Z,2017-14455,0,0,090000648290bc0f
FDA-2016-E-0627-0005,FDA,FDA-2016-E-0627,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2017-06-07T04:00:00Z,2017,6,2017-06-07T04:00:00Z,,2017-06-07T16:05:47Z,,0,0,09000064826a1f20
FDA-2016-E-0627-0004,FDA,FDA-2016-E-0627,Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T12:38:01Z,,0,0,0900006482439152
FDA-2016-E-0627-0003,FDA,FDA-2016-E-0627,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2016-05-02T04:00:00Z,2016,5,2016-05-02T04:00:00Z,,2016-05-02T22:33:02Z,,0,0,0900006481fa1c6c
FDA-2016-E-0627-0001,FDA,FDA-2016-E-0627,Patent Extension Application from Morrison & Foerster LLP (on behalf of Cerus Corporation),Other,Application,2016-02-24T05:00:00Z,2016,2,2016-02-24T05:00:00Z,,2016-02-24T23:49:14Z,,0,0,0900006481e79125
FDA-2016-E-0627-0002,FDA,FDA-2016-E-0627,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-02-24T05:00:00Z,2016,2,2016-02-24T05:00:00Z,,2016-02-24T23:49:22Z,,0,0,0900006481e79127